15 July 2024
: Case report 
Optic Neuritis Leading to Vision Loss: A Case of MOG-Associated Disease with Successful Immunotherapy
Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Unexpected drug reaction, Rare disease, Educational Purpose (only if useful for a systematic review or synthesis)
Meng-meng WangACEFG, Tao HuangABCDEF, Jia-xun LiACD, Yang YaoABC, Ying ChenABC, Kai-kai FuABD, Wen-rong MiaoBCD, Yi HanACDFGDOI: 10.12659/AJCR.943112
Am J Case Rep 2024; 25:e943112
Figure 1. Initial cranial magnetic resonance imaging (MRI) of a 42-year-old woman with positive antibody testing for myelin oligodendrocyte glycoprotein (MOG). (A, B) the T2 sequence shows bilateral optic nerve thickening, tortuosity, and swelling, and the involvement ranges from the intraorbital segment nerve without involving the optic cross, especially on the right side. (C, D) T2 pressure lipid sequence shows bilateral optic nerve thickening, tortuosity, and swelling. The involved area extends from the intraorbital segment nerve without the optic cross, especially on the right side. MOG – myelin oligodendrocyte glycoprotein; MRI – magnetic resonance imaging.